Sports Ortho Miami

Regenerative Solutions for Recovery and Repair

1. Important Regulatory Disclosure:

Peptide therapies discussed on this page are not FDA-approved drugs. They are compounded by licensed U.S. pharmacies under physician prescription and have not been evaluated through clinical trials required for FDA drug approval. This page is provided for educational and informational purposes only and does not constitute medical advice. Peptide therapy should only be undertaken under the direct supervision of a licensed physician.

As a board-certified orthopaedic surgeon and sports medicine specialist practicing in Coral Gables and serving patients throughout South Florida, Dr. John Phillip Wilkerson Jr. is committed to offering the most advanced, evidence-informed treatment options available.

Dr. Wilkerson integrates peptide protocols into a comprehensive orthopaedic treatment framework that prioritizes patient safety, physician oversight, and transparent communication about the current state of the science.

2. What Are Peptides?

Peptides are short chains of amino acids — the building blocks of proteins — that serve as signaling molecules throughout the body. Many peptides occur naturally and play essential roles in tissue repair, immune regulation, inflammation modulation, and cellular communication. Synthetic versions of these naturally occurring peptides have become a significant area of interest in regenerative medicine and orthopaedic recovery.

Unlike traditional pharmaceuticals that target symptoms, peptide therapies are designed to work with the body’s existing biological pathways to support healing at the cellular level.

3. Peptide Therapies Offered for Orthopaedic Recovery

BPC-157 (Body Protection Compound-157)

BPC-157 is a synthetic peptide derived from a protein naturally found in human gastric juice. It has been extensively studied in preclinical (animal) models for its potential role in:

  • Tendon and ligament repair

  • Musculoskeletal recovery following sports injuries

  • Gut healing and mucosal integrity

  • Reduction of inflammation

  • Promotion of angiogenesis (new blood vessel formation)

Regulatory Status (as of April 2026):

BPC-157 was placed on the FDA’s Category 2 restricted list in 2023. In February 2026, HHS announced that BPC-157 is among approximately 14 peptides expected to be reclassified from Category 2 back to Category 1 — restoring the legal pathway for compounding under physician prescription. Dr. Wilkerson’s practice sources all peptides exclusively from U.S.-licensed, FDA-registered compounding pharmacies that comply with USP 797 and USP 795 quality standards.

TB-500 (Thymosin Beta-4 Fragment)

TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in cell migration, tissue repair, and wound healing. Preclinical research has investigated TB-500 for:

  • Muscle repair and recovery

  • Flexibility and joint mobility

  • Wound healing and tissue remodeling

  • Reduction of inflammation following musculoskeletal injury

Regulatory Status:

Like BPC-157, TB-500 is expected to return to Category 1 status under the anticipated 2026 reclassification. No completed human randomized controlled trials have been published for TB-500.

4. Additional Peptides Under Physician Evaluation

Dr. Wilkerson’s practice monitors the evolving regulatory and scientific landscape for:

  • GHK-Cu (Copper Peptide): Studied for collagen synthesis and tissue remodeling.

  • KPV: An anti-inflammatory tripeptide fragment researched for immune modulation.

  • MOTS-C: A mitochondrial peptide studied for metabolic regulation and energy.

  • CJC-1295 / Ipamorelin: Growth hormone–releasing peptides studied for sleep, metabolism, and body composition.

5. How Peptide Therapy Integrates with Orthopaedic Care

Peptide protocols are incorporated as part of a comprehensive care plan that may include:

  • Arthroscopic surgery and Joint replacement surgery

  • PRP therapy and Stem cell therapy

  • Micro-Fragmented Adipose Tissue therapy

  • Physical therapy and rehabilitation

6. What to Expect During a Peptide Therapy Consultation

  • Comprehensive Health History Review 2. Laboratory Testing (Bloodwork and relevant diagnostic imaging)

  • Individualized Protocol Design (Tailored selection, dosing, and duration)

  • Ongoing Monitoring (Regular follow-up for safety and response)

  • Integration with Your Broader Care Plan

7. Frequently Asked Questions

Are peptides FDA-approved?

No. Specific regenerative peptides like BPC-157 and TB-500 are not FDA-approved drugs. They are legally prepared by licensed compounding pharmacies under physician prescription.

Animal models haven’t shown significant toxicity, but human safety data is limited. Side effects can include injection site discomfort or mild fatigue.

Via subcutaneous, intramuscular, or intra-articular injection, or oral formulation, depending on the clinical indication.

WADA has prohibited BPC-157 and other peptides under the S0 category. Athletes should discuss this with Dr. Wilkerson before beginning therapy.

8. Why Choose Dr. Wilkerson for Peptide Therapy in South Florida

Dr. John Phillip Wilkerson Jr. brings over two decades of experience as a board-certified orthopaedic surgeon. As a Fellow of the American Academy of Orthopaedic Surgeons, he offers a level of clinical expertise that distinguishes his approach from wellness clinics or medspas. His practice serves patients across Coral Gables, Brickell, South Miami, Doral, Miami Lakes, Hollywood, and Miramar.

9. Disclaimers

  • Medical Disclaimer: Educational information only; not medical advice.

  • Regulatory Disclaimer: Compounded peptides are not FDA-approved drugs. Status reflects the landscape as of April 2026.

  • Results Disclaimer: Individual results vary; no specific outcomes are guaranteed.

  • Athletic Competition Disclaimer: Certain peptides are prohibited by WADA and professional sports organizations.